ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009

Certification Means More Money for Nurses, ONS Finds

June 29, 1990

NCI Contract Process Requires Eight Months, Probably Will Get Longer As Program Grows

February 8, 1974

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991

Alternative Medicine: Testing The Boundaries Of Science

May 15, 1998

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982